Bond Bull Market May Pause but Remains Intact Expert Suggests Gladstone LANDO Stock Consolidating at 2091 Next Move Ahead 20260514 BriaCell BCTXL Climbs 381 Resistance at 114 in Focus 20260514 Dr RDY Rallies 126 as Bulls Target 1434 20260515 GlobalFoundries Launches Quantum Technology Solutions Unit Backed by 375 Million CHIPS Award World Bank Data Indicates Automation Could Threaten 69 of Jobs in India 62YearOld Engineer With 14 Million Taps 401k Early Defying Wait Until 70 Social Security Advice Subramanian Swamy Calls for Ban on Cement Imports From Pakistan Over Security Concerns Equities Close Higher as Technology and Healthcare Lead SP 500 Adds 062 Analysts Eye ResMeds Sleep Tech Dominance What the Ratings Suggest Plexus Corp Q1 2026 Earnings EPS Beats Estimates by 678 Revenue Data Withheld Moelis Company Q1 2026 Earnings EPS Misses Estimates Amid Cautious Advisory Environment Passage Bio Inc PASG Q1 2026 Earnings NarrowerThanExpected Loss Fuels Share Gains PTHS Q1 2026 Earnings Narrowed Loss Per Share Beats Estimates No Revenue Yet CLMT Q1 2026 Earnings Staggering EPS Miss Overshadowed by Positive Stock Movement Paylocity Q1 2026 Earnings EPS Surprises to the Upside Stock Gains XBiotech Inc XBIT Edges Higher Approaching Key Resistance at 256 Smith Wesson Brands Inc SWBI Sees Modest Uptick as Stock Tests Key Resistance CocaCola Consolidated COKE Holds Near Resistance Amid Modest Decline FAX Edges Higher as AsiaPacific Income Fund Holds Above Key Support NRG Energy NRG Dips 128 as Consolidation Tests Key Support Levels Dow Futures Rise as Oil Prices Tumble on Potential Iran Deal Trump Notes No Rush Milestone Pharmaceuticals MIST Q1 2026 Earnings Significant EPS Miss as PreRevenue Biotech Continues Pipeline Development Commercial Metals Co CMC Surges 38 as Steel Demand Optimism Returns XTKG Q4 2019 Earnings Massive EPS Miss and Significant Stock Decline IOR Q4 2024 Earnings Positive Earnings Amid Limited Market Visibility NCDL Q1 2026 Earnings EPS Miss Expected Stock Slips ITGR Q1 2026 Earnings EPS Slightly Misses Estimates Amid Mixed Conditions GNPX Q1 2026 Earnings ClinicalStage Biotech Reports Net Loss with No Revenue Stock Moves Up 074 GNLN Q2 2023 Earnings Massive EPS Miss with No Revenue Disclosed Stock Rises 435 ARW Q1 2026 Earnings Massive EPS Beat of 81 but Stock Slides Slightly